Informasjon
Brysthinnekreft, mesoteliom
Brysthinnekreft, mesoteliom, er en sjelden kreftsykdom. De aller fleste som får sykdommen, har vært eksponert for asbest.
Sist oppdatert:
9. mars 2022
Vil du vite mer
Dette dokumentet er basert på det profesjonelle dokumentet Mesoteliom . Referanselisten for dette dokumentet vises nedenfor
Referanser
- Tan WW. Mesothelioma. Medscape, Oct 06, 2020. emedicine.medscape.com
- Robinson BWS, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005; 353: 1591-603. PubMed
- Wagner JC, Sleggs CA and Marchand P. Diffuse pleural mesothelioma. Br J Ind Med 1960; 17: 260-71. PubMed
- Helland, Å., S. Solberg, and O.T. Brustugun, Incidence and survival of malignant pleural mesothelioma in norway: a population-based study of 1686 cases. J Thorac Oncol, 2012; 7: 1858-61.
- Helsedirektoratet. Nasjonalt handlingsprogram med retningslinjer for diagnostikk, behandling og oppfølging av lungekreft, mesoteliom og thymom, 2019. www.helsebiblioteket.no
- Kreftregisteret. Cancer in Norway 2019. Oslo 2020. www.kreftregisteret.no.
- Cugell DW, Kamp DW. Asbestos and the pleura: a review. Chest. 2004;125:1103-1117. PubMed
- Taub R, Hesdorffer M. Mesothelioma. BestPractice, last updated Dec 13, 2012 .
- Robinson BWS, Musk AW, Lake RA. Malignant mesothelioma. Lancet 2005; 366: 397-408. PubMed
- Sørensen JB. Mesothelioma. I: Hiddemann W, Bartram CR, Huber H, red. Die Oncologie. Lehrbuch der Klinischen Oncologie. Berlin-Heidelberg: Springer-Verlag, 2004: 1358-76.
- Scherpereel A, Astoul P, Baas P et al. Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma. Eur Respir J 2010; 35: 479-95. PubMed
- Sørensen JB. Diagnostik af malignt pleuralt mesoteliom. Ugeskr Læger 2010; 172: 2669. Ugeskrift for Læger
- Stewart DJ, Martin-Ucar A, Pilling JE, Edwards JG, O'Byrne KJ and Waller DA. The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma. Ann Thorac Surg 2004; 78: 245-52. PubMed
- Shaw PHS, Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database of Systematic Reviews 2013, Issue 11. Art. No.: CD002916. DOI: 10.1002/14651858.CD002916.pub3 DOI
- Kindler HL Ismaila N Armato SG 3rd, et al. Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2018 Jan 18:JCO2017766394 . pmid:29346042 PubMed
- Zellos L, Jaklitsch MT, Al-Mourgi MA, et al. Complications of extrapleural pneumonectomy. Semin Thorac Cardiovasc Surg. 2007;19:355-359. PubMed
- O'Reilly KMA, McLaughlin AM, Beckett WS. Asbestos-related lung disease. Am Fam Physician 2007; 75: 683-8. American Family Physician
- O'Byrne KJ, Edwards JG and Waller DA. Clinico-pathological and biological prognostic factors in pleural malignant mesothelioma. Lung Cancer 2004; 45: S45-S48.